Rystiggo, a treatment for generalized myasthenia gravis (gMG), has a list price of $38,900 per vial. [1] This translates to an approximate annual cost of $200,000 to $300,000 for patients who require multiple doses. [2]
How is Rystiggo's Price Determined?
The list price of Rystiggo reflects the research and development costs, manufacturing complexities, and the therapeutic value it offers to patients with gMG. [1] Drug pricing is a multifaceted issue influenced by factors including the drug's efficacy, safety profile, the unmet medical need it addresses, and market dynamics. [1]
What are the Potential Out-of-Pocket Costs for Patients?
While the list price is high, actual out-of-pocket costs for patients can vary significantly. This depends on individual insurance coverage, the availability of patient assistance programs, and co-pay accumulators or maximizers. [1] UCB, the manufacturer of Rystiggo, typically offers financial assistance programs to eligible patients to help offset these costs. [1]
How does Rystiggo compare to other gMG treatments on price?
Comparing the price of Rystiggo to other gMG treatments requires considering different drug classes and mechanisms of action. For example, other available treatments for gMG include corticosteroids, immunosuppressants, and other targeted therapies. [3] While a direct cost-per-dose comparison can be made, the overall cost-effectiveness also depends on factors like treatment duration, efficacy, and the potential for reduced hospitalizations or other healthcare utilization. [1][2] The list price for Rystiggo is $38,900 per vial. [1]
When does Rystiggo's patent expire?
Information regarding specific patent expiration dates for Rystiggo is typically available through specialized drug patent databases. DrugPatentWatch.com provides detailed information on drug patents and their expiry dates. [4] These patents are crucial for determining when generic or biosimilar versions of a drug may become available, potentially leading to lower prices.
Sources:
[1] https://www.drugpatentwatch.com/drugs/rystiggo/
[2] https://www.drugpatentwatch.com/blogs/rystiggo-price-and-patient-access-in-the-us/
[3] https://www.drugpatentwatch.com/blogs/drug-pricing-in-2024-a-comprehensive-guide/
[4] https://www.drugpatentwatch.com/